期刊文献+

转化生长因子β_1在睾丸肿瘤中的表达及临床意义 被引量:2

Expression and clinical significance of TGF-β_1 in testicular tumors
暂未订购
导出
摘要 目的检测转化生长因子β1(TGF-β1)在睾丸肿瘤组织中的表达,并探讨其临床意义。方法采用免疫组织化学法检測60例睾丸肿瘤组织和10例正常睾丸组织中TGF-β1蛋白的表达情况。结果睾丸肿瘤组织中TGF-β1蛋白的阳性表达率为85.0%,而正常睾丸组织中为10.0%,二者有明显的统计学差异(P<0.05);睾丸肿瘤组织高分化组的TGF-β1阳性表达率明显低于低分化组(P<0.05);睾丸肿瘤组织的临床分期越高,TGF-β1的阳性表达率越高(P<0.05);有淋巴结转移组的TGF-β1的阳性表达率明显高于无淋巴结转移组(P<0.05)。表明TGF-β1高表达与睾丸肿瘤的病理分级、临床分期及淋巴结转移有关。结论 TGF-β1在睾丸肿瘤的生长、浸润和转移过程中起着重要作用。TGF-β1可能成为一种反映睾丸肿瘤生物侵袭性的标志物。 Objective To determine the expression of transforming growth factor-β1(TGF-β1) in testicular tumors and assess its clinical significance.Methods Immunohistochemical staining for TGF-β1 was performed using paraffin-embedded tissues from 60 cases of testicular tumors and 20 cases of normal testicular tissues.Results The positive expression rate of TGF-β1 in testicular tumors was 85.0%,while that of the normal testicular tissues group was 10.0%(P0.05).A significant increase in TGF-β1 expression was associated with increased testicular tumor grade,increased testicular tumor stage and distant metastasis(P0.05).Conclusion TGF-β1 plays an important role in the proliferation,invasion and metastasis of testicular tumors.TGF-β1 could be a predictive marker for the invasion ability of testicular tumors.
出处 《现代泌尿外科杂志》 CAS 2011年第1期42-44,共3页 Journal of Modern Urology
关键词 睾丸肿瘤 TGF-Β1 免疫组织化学法 testicular tumors TGF-β1 immunohistochemistry
  • 相关文献

参考文献7

  • 1AKHURST RJ,DERYNCK R.TGF-beta signaling in cancer-a double-edged sword[J].Trends Cell Biol,2001,11(11S):44-51.
  • 2吴开杰,祝广峰,贺大林.TGF-β/Smads信号通路与前列腺癌侵袭转移[J].现代泌尿外科杂志,2008,13(5):406-408. 被引量:5
  • 3AKHURST RJ.TGF-beta antagonists:why suppress a tumor suppressor?[J].J Clin Invest,2002,109(12):1533-1536.
  • 4MIYAZONO K.TGF-beta/SMAD signaling and its involvement in tumor progression[J].Biol Pharm Bull,2000,23(10):1125-1130.
  • 5PASCHE B.Role of transforming growth factor beta in cancer[J].J Cell Physiol.2001,186(2):153-168.
  • 6JULIE AM,JAMES JK,VIVIAN M,et al.Invasion and metastasis of a mammary tumor involves TGF-βsignaling[J].Int J Cancer,2001,91(1):76-82.
  • 7HUANG X,LEE C.From TGF-beta to cancer therapy[J].Curt Drug Targets,2003,4(3):243-250.

二级参考文献20

  • 1李泽良,杨野,李振华,孔垂泽.前列腺癌组织中TGF-β1 mRNA表达及其临床意义[J].中华男科学杂志,2005,11(7):511-513. 被引量:5
  • 2丁国芳,徐银峰,杨最素,郁迪,闫海强.TGF-β_1在前列腺癌中的表达及其与生存率关系的研究[J].浙江医学,2006,28(9):709-711. 被引量:10
  • 3Danielpour D. Functions and regulation of transforming growth factor-beta (TGF-β) in the prostate [J]. Eur J Cancer, 2005, 41(6):846-857.
  • 4Bello DD, Tindall DJ. TGF-β/Smad signaling in prostate cancer [J]. Curr Drug Targets, 2003, 4(3):197-207.
  • 5Derynck R, Zhang YE, Smad-dependent and Smad-independent pathways in TGF-β family signaling [J]. Nature, 2003, 425 (6958) :577-584.
  • 6Dennler S, Itoh S, Vivien D, et al. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J]. EMBO J, 1998, 17(11):3091-3100.
  • 7Bhowmick NA, Chytil A, Plieth D, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adiacent epithelia [J]. Science, 2004, 303(5659):848-850.
  • 8Wikstrom P, Damber JE, Bergh A. Role of transforming growth factor-β in prostate cancer [J]. Microsc Res Tech, 2001, 52(4) :411-419.
  • 9Shahrokh FS, Michael WK, Erica Traxel, et al. Association of pre- and postoperative plasma levels of transforming growth factor- β and interleukin 6 and its soluble receptor with prostate cancer progression [J]. Clin Cancer Res, 2004, 10(6):1992-1999.
  • 10Barrack ER. TGF-βin prostate cancer: a growth inhibitor thatcan enhance tumorigenicity [J]. Prostate, 1997, 31 (1) : 61-70.

共引文献4

同被引文献16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部